BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17517478)

  • 1. Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
    Gillis AM; Sutton E; Dewitt KD; Matthay KK; Weinberg V; Fisch BM; Chan A; Gooding C; Daldrup-Link H; Wara WM; Farmer DL; Harrison MR; Haas-Kogan D
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):858-64. PubMed ID: 17517478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of local recurrence after intraoperative radiotherapy for advanced neuroblastoma.
    Kunieda E; Hirobe S; Kaneko T; Nagaoka T; Kamagata S; Nishimura G
    Jpn J Clin Oncol; 2008 Aug; 38(8):562-6. PubMed ID: 18667476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent local control from radiation therapy for high-risk neuroblastoma.
    Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
    Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of external-beam radiotherapy with intraoperative electron-beam therapy is effective in incompletely resected pediatric malignancies.
    Oertel S; Niethammer AG; Krempien R; Roeder F; Eble MJ; Baer C; Huber PE; Kulozik A; Waag KL; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):235-41. PubMed ID: 16257132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
    Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
    Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control, survival, and operative morbidity and mortality after re-resection, and intraoperative radiation therapy for recurrent or persistent primary high-risk neuroblastoma.
    Rich BS; McEvoy MP; LaQuaglia MP; Wolden SL
    J Pediatr Surg; 2011 Jan; 46(1):97-102. PubMed ID: 21238648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
    Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
    J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy for parotid cancer: a single-institution experience.
    Zeidan YH; Shiue K; Weed D; Johnstone PA; Terry C; Freeman S; Krowiak E; Borrowdale R; Huntley T; Yeh A
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1831-6. PubMed ID: 21514074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
    von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
    J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
    Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
    Med Pediatr Oncol; 2003 Apr; 40(4):214-8. PubMed ID: 12555247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial base chordoma--long term outcome and review of the literature.
    Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y
    Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.
    Lin LL; El Naqa I; Leonard JR; Park TS; Hollander AS; Michalski JM; Mansur DB
    J Neurosurg Pediatr; 2008 Feb; 1(2):126-30. PubMed ID: 18352781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for scoliosis in children with neuroblastoma.
    Paulino AC; Fowler BZ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):865-9. PubMed ID: 15708267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.
    Ballo MT; Zagars GK; Pollock RE; Benjamin RS; Feig BW; Cormier JN; Hunt KK; Patel SR; Trent JC; Beddar S; Pisters PW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):158-63. PubMed ID: 17084545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
    Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
    Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results of neuroblastoma in children in the Republic of Belarus].
    Proleskovskaia IV; Savich TV; Mareĭko IuE; Savva NN; Aleĭnikova OV
    Vopr Onkol; 2009; 55(2):215-20. PubMed ID: 19514379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience.
    Valentini V; Calvo F; Reni M; Krempien R; Sedlmayer F; Buchler MW; Di Carlo V; Doglietto GB; Fastner G; Garcia-Sabrido JL; Mattiucci G; Morganti AG; Passoni P; Roeder F; D'Agostino GR
    Radiother Oncol; 2009 Apr; 91(1):54-9. PubMed ID: 18762346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.